EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 0.6050
-0.1150 (-15.97%)
At close: Sep 11, 2026
EXACT Therapeutics AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 49.1 | 24.35 | 99.54 | 46.43 | 69.39 | 82.91 |
Short-Term Investments | - | - | - | - | - | 20.78 |
Cash & Short-Term Investments | 49.1 | 24.35 | 99.54 | 46.43 | 69.39 | 103.69 |
Cash Growth | -16.07% | -75.54% | 114.38% | -33.09% | -33.08% | -35.08% |
Other Receivables | 9.88 | 7 | 6.69 | 8.64 | 8.14 | 7.61 |
Receivables | 9.88 | 7 | 6.69 | 8.64 | 8.14 | 7.61 |
Other Current Assets | 19.92 | 29.16 | 26.98 | 0.83 | - | - |
Total Current Assets | 79.27 | 60.51 | 133.21 | 55.9 | 77.53 | 111.3 |
Property, Plant & Equipment | 5.75 | 6.89 | 4.81 | 5.42 | 4.97 | 6.33 |
Other Long-Term Assets | - | - | 15.19 | 0 | 0 | - |
Total Assets | 85.02 | 67.4 | 153.2 | 61.32 | 82.51 | 117.63 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.17 | 7.45 | 11.66 | 7.21 | 9.55 | 3.18 |
Accrued Expenses | 11 | 9.59 | 7.27 | 6.17 | 4.71 | 6.33 |
Current Portion of Leases | 0.06 | 0.43 | 0.59 | 0.55 | 0.5 | 0.36 |
Other Current Liabilities | 1.84 | 19.22 | 18.08 | 1.56 | 1.37 | 0.66 |
Total Current Liabilities | 19.08 | 36.69 | 37.6 | 15.49 | 16.13 | 10.53 |
Long-Term Leases | - | - | 0.05 | 0.65 | 1.19 | 1.35 |
Other Long-Term Liabilities | -0 | 0 | - | 0.12 | 0.08 | 0 |
Total Liabilities | 19.08 | 36.69 | 37.65 | 16.26 | 17.4 | 11.89 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.45 | 0.25 | 0.25 | 0.13 | 0.12 | 0.12 |
Additional Paid-In Capital | 82.32 | 9.67 | 96.64 | 29.44 | 93.52 | 215.63 |
Retained Earnings | -38 | - | - | - | -40.1 | -122.01 |
Comprehensive Income & Other | 21.18 | 20.78 | 18.65 | 15.49 | 11.57 | 12.01 |
Shareholders' Equity | 65.94 | 30.71 | 115.55 | 45.06 | 65.11 | 105.74 |
Total Liabilities & Equity | 85.02 | 67.4 | 153.2 | 61.32 | 82.51 | 117.63 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.06 | 0.43 | 0.65 | 1.2 | 1.69 | 1.71 |
Net Cash (Debt) | 49.04 | 23.91 | 98.89 | 45.23 | 67.7 | 101.97 |
Net Cash Growth | -15.67% | -75.82% | 118.61% | -33.19% | -33.61% | -36.14% |
Net Cash Per Share | 0.56 | 0.38 | 2.85 | 1.41 | 2.26 | 3.40 |
Filing Date Shares Outstanding | 63.26 | 63.26 | 63.26 | 32.08 | 30 | 29.99 |
Total Common Shares Outstanding | 63.26 | 63.26 | 63.26 | 32.08 | 30 | 29.99 |
Working Capital | 60.19 | 23.82 | 95.61 | 40.41 | 61.41 | 100.76 |
Book Value Per Share | 1.04 | 0.49 | 1.83 | 1.40 | 2.17 | 3.53 |
Tangible Book Value | 65.94 | 30.71 | 115.55 | 45.06 | 65.11 | 105.74 |
Tangible Book Value Per Share | 1.04 | 0.49 | 1.83 | 1.40 | 2.17 | 3.53 |
Machinery | - | 18.14 | 12.96 | 11.28 | 8.22 | 8.02 |